Who owns the ALFACYTE trademark?

The ALFACYTE trademark is owned by ILC Therapeutics Limited.

What class is the ALFACYTE trademark registered in?

The ALFACYTE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for ALFACYTE?

The USPTO serial number for ALFACYTE is 79327654.

What is the registration number for ALFACYTE?

ALFACYTE is registered under USPTO registration number 7008476.

Sealvo

Home Search: ALFACYTEALFACYTE #79327654

Back

Updated Oct 28, 2026·40 searches this week

View on USPTO TSDR Find similar marks

ALF

USPTO Trademark Record

REGISTERED

ALFACYTE

SN 79327654·Reg 7008476·Filed Sep 16, 2021

Owner ILC Therapeutics Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

ALFACYTE (Serial No. 79327654), Registration No. 7008476, is a registered US trademark filed on Sep 16, 2021 by ILC Therapeutics Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: March 28, 2029

Mark Intelligence

ALFACYTE (Reg. #7008476) is a registered US trademark that has been protecting its owner, ILC Therapeutics Limited, since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Sep 16, 2021

SERIAL

79327654

REG#

7008476

REGISTERED

Mar 28, 2023

Filing Information

StatusREGISTERED

Filing DateSep 16, 2021

Serial Number79327654

Registration No.7008476

Registration DateMar 28, 2023

Status DateMar 28, 2023

Published for OppositionJan 10, 2023

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

27 events

NEW REPRESENTATIVE AT IB RECEIVED

Nov 21, 2025

NEW REPRESENTATIVE AT IB RECEIVED

FINAL DECISION TRANSACTION PROCESSED BY IB

Aug 07, 2023

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Jul 18, 2023

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Jul 18, 2023

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jun 28, 2023

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Mar 28, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 28, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTIFICATION PROCESSED BY IB

Jan 24, 2023

NOTIFICATION PROCESSED BY IB

PUBLISHED FOR OPPOSITION

Jan 10, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 10, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Jan 04, 2023

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Jan 04, 2023

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 21, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 08, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Nov 17, 2022

ASSIGNED TO EXAMINER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 15, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 15, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 15, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Jul 19, 2022

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Jun 25, 2022

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jun 25, 2022

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jun 23, 2022

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Jun 22, 2022

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Jun 21, 2022

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Dec 14, 2021

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 10, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Dec 09, 2021

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by ILC Therapeutics Limited

Additional USPTO filings from the same owner.

CAN

CANIFERON

79327653

ILC Therapeutics Limited

REGISTERED

Other Marks by Brian M. Davis

Additional USPTO filings handled by the same attorney of record.

MAC

MACLEOD'S

99728845

REGISTERED

GHO

GHOST VFX

88927841

REGISTERED

IMP

IMPERIAL

88441721

REGISTERED

VER

VERSASEAL

99178040

REGISTERED

ALFACYTE

Run a conflict check

Other Marks by ILC Therapeutics Limited

Other Marks by Brian M. Davis

Get pre-filing clearance

Search 14M+ trademarks

Industries

USPTO Deadlines

Compare

Resources

Company